Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study

British Journal of Cancer

Volumn 108, Issue 11, 2013, Pages 2390-2398

  Murphy, F ^a   Kroll, M E ^a   Pirie, K ^a   Reeves, G ^a   Green, J ^a   Beral, V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Body mass index; Cohort; Haematological malignancy; Height; Leukaemia; Lymphoma

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; FOLLICULAR LYMPHOMA; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PLASMACYTOMA; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM; AGED; HEMATOLOGIC DISEASE; OBESITY; PROPORTIONAL HAZARDS MODEL;

ADIPOSITY; AGED; BODY MASS INDEX; BODY SIZE; FEMALE; GREAT BRITAIN; HEMATOLOGIC NEOPLASMS; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84884200028     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.159     Document Type: Article

References (46)

1. Armstrong ME, Spencer EA, Cairns BJ, Banks E, Pirie K, Green J, Wright FL, Reeves GK, Beral V (2011) Body mass index and physical activity in relation to the incidence of hip fracture in postmenopausal women. J Bone Miner Res 26(6): 1330-1338.
2. Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NF-kappa B as the matchmaker. Nat Immunol 12(8): 715-723.
3. Britton JA, Khan AE, Rohrmann S, Becker N, Linseisen J, Nieters A, Kaaks R, Tjonneland A, Halkjaer J, Severinsen MT, Overvad K, Pischon T, Boeing H, Trichopoulou A, Kalapothaki V, Trichopoulos D, Mattiello A, Tagliabue G, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Ardanaz E, Navarro C, Jakszyn P, Altzibar JM, Hallmans G, Malmer B, Berglund G, Manjer J, Allen N, Key T, Bingham S, Besson H, Ferrari P, Jenab M, Boffetta P, Vineis P, Riboli E (2008) Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 93(11): 1666-1677.
4. Cairns BJ, Liu B, Clennell S, Cooper R, Reeves GK, Beral V, Kuh D (2011) Lifetime body size and reproductive factors: comparisons of data recorded prospectively with self reports in middle age. BMC Med Res Methodol 11: 7.
5. Cerhan JR, Bernstein L, Severson RK, Davis S, Colt JS, Blair A, Hartge P (2005) Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 16(10): 1203-1214.
6. Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR (2002) Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 156(6): 527-535.
7. Chang ET, Hjalgrim H, Smedby KE, Akerman M, Tani E, Johnsen HE, Glimelius B, Adami HO, Melbye M (2005) Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97(3): 210-218.
8. Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA (2006) Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 15(4): 630-638.
9. Claycombe K, King LE, Fraker PJ (2008) A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci USA 105(6): 2017-2021.
10. Engeland A, Tretli S, Hansen S, Bjorge T (2007) Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 165(1): 44-52.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, DMP (2010) Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. In GLOBOCAN 2008. International Agency for Research on Cancer: Lyon, France.
12. Gorber SC, Tremblay M, Moher D, Gorber B (2007) A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 8(4): 307-326.
13. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12(8): 785-794.
14. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29: 415-445.
15. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23(2): 313-342.
16. IARC (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC): Lyon, France.
17. Kasim K, Levallois P, Abdous B, Auger P, Johnson KC (2005) Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control 16(5): 489-500.
18. Kroll ME, Murphy F, Pirie K, Reeves GK, Green J, Beral V (2012) Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study. Br J Cancer 107(5): 879-887.
19. Lam QL, Wang S, Ko OK, Kincade PW, Lu L (2010) Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1. Proc Natl Acad Sci USA 107(31): 13812-13817.
20. Larsson SC, Wolk A (2008) Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 122(6): 1418-1421.
21. Larsson SC, Wolk A (2011) Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47(16): 2422-2430.
22. Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, Kipnis V, Mouw T, Carroll L, Schatzkin A, Hartge P (2007) Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 166(6): 697-708.
23. Lu Y, Prescott J, Sullivan-Halley J, Henderson KD, Ma H, Chang ET, Clarke CA, Horn-Ross PL, Ursin G, Bernstein L (2009) Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am J Epidemiol 170(10): 1231-1240.
24. Ma X, Lim U, Park Y, Mayne ST, Wang R, Hartge P, Hollenbeck AR, Schatzkin A (2009) Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol 169(12): 1492-1499.
25. NICE (2003) Improving Outcomes in Haematological Cancer: The Manual. National Institute for Clinical Excellence: London.
26. Pan SY, Mao Y, Ugnat AM (2005) Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol 162(12): 1162-1173.
27. Phekoo KJ, Richards MA, Moller H, Schey SA (2006) The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica 91(10): 1400-1404.
28. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4(7): 505-518.
29. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ 335(7630): 1134-1139.
30. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612): 569-578.
31. Rosenfeld RG, Hwa V (2009) The growth hormone cascade and its role in mammalian growth. Horm Res 71(Suppl 2): 36-40.
32. Ross JA, Parker E, Blair CK, Cerhan JR, Folsom AR (2004) Body mass index and risk of leukemia in older women. Cancer Epidemiol Biomarkers Prev 13(11 Pt 1): 1810-1813.
33. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the Inter Lymph Consortium. Lancet Oncol 7(1): 27-38.
34. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F, Hackl M, Holub J, Maynadie M, Holleczek B, Tryggvadottir L, Comber H, Bellù F, Giacomin A, Ferretti S, Crocetti E, Serraino D, Vercelli M, Federico M, Fusco M, Michiara M, Tumino R, Mangone L, Falcini F, Iannelli A, Budroni M, Zanetti R, Piffer S, La Rosa F, Zambon P, Sowe S, England K, Langmark F, Rachtan J, Mezyk R, Zwierko M, Ondrusova M, Primic-Žakelj M, Khan S, Jundt G, Usel M, Ess SM, Bordoni A, Otter R, Coebergh JW, Siesling S, Greenberg D, Easey N, Roche M, Lawrence G, Gavin A, Brewster DH, Steward J (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project. Blood 116(19): 3724-3734.
35. SEER (2001) ICD-O-2 to ICD-O-3 Neoplasms; available at: http://seer.cancer.gov/tools/conversion/ICDO2-3manual.pdf, National Cancer Institute.
36. Silventoinen K (2003) Determinants of variation in adult body height. J Biosoc Sci 35(2): 263-285.
37. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Hegedus C, Smith MT (2004) Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13(5): 779-786.
38. Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A (2010) The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 148(5): 739-753.
39. Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, Berrino F, van den Brandt PA, Buring JE, Cho E, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Harnack L, Horn-Ross PL, Krogh V, Leitzmann MF, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Schatzkin A, Shore R, Virtanen M, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Hunter DJ (2006) Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 163(11): 1053-1064.
40. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10): 772-783.
41. Troy JD, Hartge P, Weissfeld JL, Oken MM, Colditz GA, Mechanic LE, Morton LM (2010) Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 171(12): 1270-1281.
42. Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BCH, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD (2010) Inter Lymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): Update and future directions. Blood 116(20): e90-e98.
43. Wallin A, Larsson SC (2011) Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 47(11): 1606-1615.
44. WHO (1995) Physical Status: The Use and Interpretation of Anthropometry. World Health Organization Expert Committee: Geneva, Switzerland.
45. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, Bracci P, Cerhan J, Chiu BC, Cocco P, Dal Maso L, Davis S, De Sanjose S, Smedby KE, Ennas MG, Foretova L, Holly EA, La Vecchia C, Matsuo K, Maynadie M, Melbye M, Negri E, Nieters A, Severson R, Slager SL, Spinelli JJ, Staines A, Talamini R, Vornanen M, Weisenburger DD, Roman E (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the Inter Lymph Consortium. Int J Cancer 122(9): 2062-2070.
46. Willett EV, Skibola CF, Adamson P, Skibola DR, Morgan GJ, Smith MT, Roman E (2005) Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 93(7): 811-816.